Jul 31 2017

British Journal of Cancer #nature, #nature #publishing #group, #bjc, #british #journal #cancer, #cancer #research, #cancers,


Welcome to BJC

Multidisciplinary Journal of Cancer Research

BJC publishes significant original papers and reviews that:

  • increase understanding of the causes of cancer
  • inform timely detection and accurate diagnosis
  • investigate molecular pathways relevant to cancer therapy
  • contribute to the discovery of novel therapies
  • help develop personalised therapy
  • drive improvements in the treatment and survival of patients

BJC is one of the most-cited general cancer journals

Vol 116, No 11

(May 2017)
ISSN 0007-0920

2015 Impact Factor
5.569 *
28/213 Oncology

*2015 Journal Citation Reports Science Edition (Thomson Reuters, 2016)

Web Focus

Immune checkpoint inhibitors are rapidly changing cancer treatment paradigms.


Guest editors: Jonathan A Ledermann

Vol 113, No S1 (December 2015)

Comprehensively reviews molecular and clinical evidence underlying the evolution of poly (ADP-ribose) polymerase (PARP) inhibitors culminating in the recent licensing approval of the first oral PARP inhibitor, for BRCA-mutated high-grade serous ovarian cancer.
Organized by AstraZeneca UK


Cell-line misidentification and contamination with microorganisms, such as mycoplasma, together with instability, both genetic and phenotypic, are among the problems that continue to affect cell culture. Many of these problems are avoidable with the necessary foresight, and these Guidelines have been prepared to provide those new to the field and others engaged in teaching and instruction with the information necessary to increase their awareness of the problems and to enable them to deal with them effectively.

Click to view these Guidelines


M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson and M Wilcox

Breast screening may save lives if aggressive cancers are detected early and treated effectively, but many screen-detected cancers would otherwise have been without symptoms during the patient’s lifetime, so does treating them cause more harm than good? This independent review, published here in full for the first time, addresses the evidence and uses this to make recommendations. The debate is taken up by four lively Editorials written by opinion leaders in the field of breast cancer treatment.

Editorials by:


Updated, enhanced, and providing practical advice on animal welfare specifically for today’s cancer researchers, these guidelines define and encourage sharing of best practice in laboratory work. Already endorsed by leading scientists worldwide, they should also be read by those making decisions about licensing, funding and publication.

Click to view these Guidelines

Featured Articles

Written by admin

Leave a Reply

Your email address will not be published. Required fields are marked *